Catalogo Articoli (Spogli Riviste)

HELP
ATTENZIONE: attualmente gli articoli Current Contents (fonte ISI) a partire dall'anno 2002 sono consultabili sulla Risorsa On-Line

Le informazioni sugli articoli di fonte ISI sono coperte da copyright

La ricerca find articoli where authors phrase all words ' Hellmann, NS' sort by level,fasc_key/DESCEND, pagina_ini_num/ASCEND ha restituito 16 riferimenti
Selezionare un intervallo

Per ulteriori informazioni selezionare i riferimenti di interesse.

    1. Kemper, CA; Witt, MD; Keiser, PH; Dube, MP; Forthal, DN; Leibowitz, M; Smith, DS; Rigby, A; Hellmann, NS; Lie, YS; Leedom, J; Richman, D; McCutchan, JA; Haubrich, R
      Sequencing of protease inhibitor therapy: insights from an analysis of HIVphenotypic resistance in patients failing protease inhibitors

      AIDS
    2. Dunne, AL; Mitchell, FM; Coberly, SK; Hellmann, NS; Hoy, J; Mijch, A; Petropoulos, CJ; Mills, J; Crowe, SM
      Comparison of genotyping and phenotyping methods for determining susceptibility of HIV-1 to antiretroviral drugs

      AIDS
    3. Price, RW; Paxinos, EE; Grant, RM; Drews, B; Nilsson, A; Hoh, R; Hellmann, NS; Petropoulos, CJ; Deeks, SG
      Cerebrospinal fluid response to structured treatment interruption after virological failure

      AIDS
    4. Deeks, SG; Wrin, T; Liegler, T; Hoh, R; Hayden, M; Barbour, JD; Hellmann, NS; Petropoulos, CJ; McCune, JM; Hellerstein, MK; Grant, RM
      Virologic and immunologic consequences of discontinuing combination antiretroviral-drug therapy in HIV-infected patients with detectable viremia.

      NEW ENGLAND JOURNAL OF MEDICINE
    5. Roland, ME; Martin, JN; Grant, RM; Hellmann, NS; Bamberger, JD; Katz, MH; Chesney, M; Franses, K; Coates, TJ; Kahn, JO
      Postexposure prophylaxis for human immunodeficiency virus infection after sexual or injection drug use exposure: Identification and characterization of the source of exposure

      JOURNAL OF INFECTIOUS DISEASES
    6. Call, SA; Saag, MS; Westfall, AO; Raper, JL; Pham, SV; Tolson, JM; Hellmann, NS; Cloud, GA; Johnson, VA
      Phenotypic drug susceptibility testing predicts long-term virologic suppression better than treatment history in patients with human immunodeficiencyvirus infection

      JOURNAL OF INFECTIOUS DISEASES
    7. Parkin, NT; Deeks, SG; Wrin, MT; Yap, J; Grant, RM; Lee, KH; Heeren, D; Hellmann, NS; Petropoulos, CJ
      Loss of antiretroviral drug susceptibility at low viral load during early virological failure in treatment-experienced patients

      AIDS
    8. Havlir, DV; Hellmann, NS; Petropoulos, CJ; Whitcomb, JM; Collier, AC; Hirsch, MS; Tebas, P; Sommadossi, JP; Richman, DD
      Drug susceptibility in HIV infection after viral rebound in patients receiving indinavir-containing regimens

      JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION
    9. Brown, AJL; Precious, HM; Whitcomb, JM; Wong, JK; Quigg, M; Huang, W; Daar, ES; D'Aquila, RT; Keiser, PH; Connick, E; Hellmann, NS; Petropoulos, CJ; Richman, DD; Little, SJ
      Reduced susceptibility of human immunodeficiency virus type 1 (HIV-1) frompatients with primary HIV infection to nonnucleoside reverse transcriptaseinhibitors is associated with variation at novel amino acid sites

      JOURNAL OF VIROLOGY
    10. Weinstock, H; Respess, R; Heneine, W; Petropoulos, CJ; Hellmann, NS; Luo, CC; Pau, CP; Woods, T; Gwinn, M; Kaplan, J
      Prevalence of mutations associated with reduced antiretroviral drug susceptibility among human immunodeficiency virus type 1 seroconverters in the United States, 1993-1998

      JOURNAL OF INFECTIOUS DISEASES
    11. Little, SJ; Daar, ES; D'Aquila, RT; Keiser, PH; Connick, E; Whitcomb, JM; Hellmann, NS; Petropoulos, CJ; Sutton, L; Pitt, JA; Rosenberg, ES; Koup, RA; Walker, BD; Richman, DD
      Reduced antiretroviral drug susceptibility among patients with primary HIVinfection

      JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION
    12. Deeks, SG; Hellmann, NS; Grant, RM; Parkin, NT; Petropoulos, CJ; Becker, M; Symonds, W; Chesney, M; Volberding, PA
      Novel four-drug salvage treatment regimens after failure of a human immunodeficiency virus type 1 protease inhibitor-containing regimen: Antiviral activity and correlation of baseline phenotypic drug susceptibility with virologic outcome

      JOURNAL OF INFECTIOUS DISEASES
    13. DEEKS SG; BARDITCHCROVO P; LIETMAN PS; HWANG F; CUNDY KC; ROONEY JF; HELLMANN NS; SAFRIN S; KAHN JO
      SAFETY, PHARMACOKINETICS, AND ANTIRETROVIRAL ACTIVITY OF INTRAVENOUS 9-[2-(R)-(PHOSPHONOMETHOXY)PROPYL]ADENINE A NOVEL ANTI-HUMAN-IMMUNODEFICIENCY-VIRUS (HIV) THERAPY, IN HIV-INFECTED ADULTS

      Antimicrobial agents and chemotherapy
    14. MULATO AS; LAMY PD; MILLER MD; LI WX; ANTON KE; HELLMANN NS; CHERRINGTON JM
      GENOTYPIC AND PHENOTYPIC CHARACTERIZATION OF HUMAN-IMMUNODEFICIENCY-VIRUS TYPE-1 VARIANTS ISOLATED FROM AIDS PATIENTS AFTER PROLONGED ADEFOVIR DIPIVOXIL THERAPY

      Antimicrobial agents and chemotherapy
    15. HECHT FM; GRANT RM; PETROPOULOS CJ; DILLON B; CHESNEY MA; TIAN H; HELLMANN NS; BANDRAPALLI NI; DIGILIO L; BRANSON B; KAHN JO
      SEXUAL TRANSMISSION OF AN HIV-1 VARIANT RESISTANT TO MULTIPLE REVERSE-TRANSCRIPTASE AND PROTEASE INHIBITORS

      The New England journal of medicine
    16. HELLMANN NS; NSUBUGA PS; BAINGANABAINGI DJ; DESMONDHELLMANN SD; MBIDDE EK; GRANOWITZ CB; SANDE MA
      SINGLE-DOSE AMPICILLIN-SULBACTAM VERSUS CEFTRIAXONE AS TREATMENT FOR UNCOMPLICATED GONORRHEA IN A UGANDAN STD CLINIC POPULATION WITH A HIGHPREVALENCE OF PPNG INFECTION

      Journal of tropical medicine and hygiene


ASDD Area Sistemi Dipartimentali e Documentali, Università di Bologna, Catalogo delle riviste ed altri periodici
Documento generato il 23/10/20 alle ore 07:03:29